City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL

June 28, 2019 | City of Hope

At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.

City of Hope awarded $7.5M to develop treatment for rare cancer

April 3, 2019 | Zen Vuong

City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.

Finding better treatments for devastating rare diseases

February 27, 2019 | Abe Rosenberg

City of Hope has long been renowned for its expertise in treating cancer and diabetes. But specialists here also are tackling lesser-known but equally devastating diseases that may or may not have an oncologic component.

From lymphoma patient to lymphoma advocate

September 5, 2018 | Samantha Bonar

With a fussy 5-month-old, Aza Khachikyan, 27, thought she was struggling with normal new-mom fatigue. Then she received a life-changing diagnosis: Hodgkin’s lymphoma.

City of Hope Physicians Announce New CAR T Breakthroughs at Annual ASH Meeting

December 14, 2017 | Letisia Marquez

New blood cancer breakthroughs – including several involving CAR T cell therapy – were announced by City of Hope physicians at the American Society of Hematology (ASH) annual meeting in Atlanta.